Bullish opportunity - Swing trade Double bottom breakout with good volumes. The stock just broken a 20-day high with trading volumes significantly above the 20-day moving average, indicating strong momentum with high market interest.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
22.00 INR
921.66 M INR
8.19 B INR
13.37 M
About ORCHID PHARMA LTD
Sector
CEO
Manish Dhanuka
Headquarters
Narsinghpur
Website
Founded
1992
ISIN
INE191A01027
FIGI
BBG000CX80T3
Orchid Pharma Ltd. engages in the provision of development, manufacture, and marketing of diverse bulk actives, formulations, and nutraceuticals. Its products include cardiovascular, anti-diabetic, neuropsychiatry, nutritional supplements, cephalosporins-orals, cephalosporins-injectables, veterinary products, and non-antibiotics. The company was founded by Kailasam Raghavendra Rao on July 1, 1992 and is headquartered in Narsinghpur, India.
Cup and handle breakoutGood volume buildup in daily and weekly timeframe.
Cup and Handle breakout with good volume and successfully retest.
Fundamental's are good.
DII stakes increased.
NOTE: I do my analysis, do yours before trade.
ORCHPHARMA Giving a Strong BreakOutOrchid Pharma Ltd. engages in the development, manufacture, and marketing of diverse bulk actives, formulations, and nutraceuticals. Its products include cardiovascular, anti-diabetic, neuropsychiatry, nutritional supplements, cephalosporins-orals, cephalosporins-injectables, veterinary products, an
ORCHPHARMA - Bullish SetupStock name - Orchid Pharma Limited.
Weekly chart setup
Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined.
Master Score - C
Disclaimer: This is for demonstration and educ
ORCHID PharmaOrchid pharma: Breakout above 1350, which was its previous high as well.
If we see a breakout with volumes then a fresh spike may come.
One can take at the re test level as well .
Disclaimer: only for education purposes, no buy or sell recommendation. we are not sebi registered. always discus
orchpharma1. Anything can happen.
2. You don't need to know what is going to happen next in order to make money.
3. There is a random distribution between wins and losses for any given set of variables that define an edge. No other thoughts
4. An edge is nothing more than an indication of a higher probability
ORCHID ready to BLOOM?!?!?There's selling pressure from upside!
But the stock seems to have formed a strong base near 950!
A long can be initiated here and buy on dips formula can be applied!
ORCHID
** Adds ORCD is set for strong growth over the next three years as new management continues to execute the turnaround strategy well
** Co leveraging core strengths in key active pharma ingredients (APIs)-like anti-microbials such as Cephalosporin,
** Estimates 35%+ compound annual growth rate (C
Orchid Pharma - New ManagementOrchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs
Product Portfolio
The Co has a multi-therapeutic presence across segments like anti-infectives, ant
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ORCHPHARMA is 1,499.35 INR — it has decreased by −0.53% in the past 24 hours. Watch ORCHID PHARMA LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange ORCHID PHARMA LTD stocks are traded under the ticker ORCHPHARMA.
ORCHPHARMA stock has risen by 2.08% compared to the previous week, the month change is a 12.13% rise, over the last year ORCHID PHARMA LTD has showed a 176.33% increase.
We've gathered analysts' opinions on ORCHID PHARMA LTD future price: according to them, ORCHPHARMA price has a max estimate of 1,650.00 INR and a min estimate of 1,641.00 INR. Watch ORCHPHARMA chart and read a more detailed ORCHID PHARMA LTD stock forecast: see what analysts think of ORCHID PHARMA LTD and suggest that you do with its stocks.
ORCHPHARMA reached its all-time high on Apr 5, 2021 with the price of 2,654.25 INR, and its all-time low was 17.15 INR and was reached on Nov 3, 2020. View more price dynamics on ORCHPHARMA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ORCHPHARMA stock is 1.95% volatile and has beta coefficient of 1.36. Track ORCHID PHARMA LTD stock price on the chart and check out the list of the most volatile stocks — is ORCHID PHARMA LTD there?
Today ORCHID PHARMA LTD has the market capitalization of 76.05 B, it has increased by 4.94% over the last week.
Yes, you can track ORCHID PHARMA LTD financials in yearly and quarterly reports right on TradingView.
ORCHID PHARMA LTD is going to release the next earnings report on Nov 11, 2024. Keep track of upcoming events with our Earnings Calendar.
ORCHPHARMA earnings for the last quarter are 5.80 INR per share, whereas the estimation was 6.90 INR resulting in a −15.94% surprise. The estimated earnings for the next quarter are 4.00 INR per share. See more details about ORCHID PHARMA LTD earnings.
ORCHID PHARMA LTD revenue for the last quarter amounts to 2.44 B INR, despite the estimated figure of 2.26 B INR. In the next quarter, revenue is expected to reach 2.34 B INR.
ORCHPHARMA net income for the last quarter is 293.51 M INR, while the quarter before that showed 329.56 M INR of net income which accounts for −10.94% change. Track more ORCHID PHARMA LTD financial stats to get the full picture.
No, ORCHPHARMA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 923.00 employees. See our rating of the largest employees — is ORCHID PHARMA LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORCHID PHARMA LTD EBITDA is 1.20 B INR, and current EBITDA margin is 13.54%. See more stats in ORCHID PHARMA LTD financial statements.
Like other stocks, ORCHPHARMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORCHID PHARMA LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORCHID PHARMA LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORCHID PHARMA LTD stock shows the buy signal. See more of ORCHID PHARMA LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.